Abstract:Accurate diagnosis of the initial phase of Alzheimer's disease (AD) is essential and crucial. The objective of this research was to employ efficient biomarkers for the diagnostic analysis and classification of AD based on combining structural MRI (sMRI) and resting-state functional MRI (rs-fMRI). So far, several anatomical MRI imaging markers for AD diagnosis have been identified. The use of cortical and subcortical volumes, the hippocampus, and amygdala volume, as well as genetic patterns, has proven to be beneficial in distinguishing patients with AD from the healthy population. The fMRI time series data have the potential for specific numerical information as well as dynamic temporal information. Voxel and graphical analyses have gained popularity for analyzing neurodegenerative diseases, such as Alzheimer's and its prodromal phase, mild cognitive impairment (MCI). So far, these approaches have been utilized separately for the diagnosis of AD. In recent studies, the classification of cases of MCI into those that are not converted for a certain period as stable MCI (MCIs) and those that converted to AD as MCIc has been less commonly reported with inconsistent results. In this study, we verified and validated the potency of a proposed diagnostic framework to identify AD and differentiate MCIs from MCIc by utilizing the efficient biomarkers obtained from sMRI, along with functional brain networks of the frequency range .01-.027 at the resting state and the voxel-based features. The latter mainly included default mode networks (amplitude of low-frequency fluctuation [ALFF], fractional ALFF [ALFF], and regional homogeneity [ReHo]), degree centrality (DC), and salience networks (SN). Pearson's correlation coefficient for measuring fMRI functional networks has proven to be an efficient means for disease diagnosis. We applied the graph theory to calculate nodal features (nodal degree [ND], nodal path length [NL], and between centrality [BC]) as a graphical feature and analyzed the connectivity link between different brain regions. We extracted three-dimensional (3D) patterns to calculate regional coherence and then implement a univariate statistical t-test to access a 3D mask that preserves voxels showing significant changes. Similarly, from sMRI, we calculated the hippocampal subfield and amygdala nuclei volume using Freesurfer (version 6). Finally, we implemented and compared the different feature selection algorithms to integrate the structural features, brain networks, and voxel features to optimize the diagnostic identifications of AD using support vector machine (SVM) classifiers. We also compared the performance of SVM with Random Forest (RF) classifiers. The obtained results demonstrated the potency of our framework, wherein a combination of the hippocampal subfield, the amygdala volume, and brain networks with multiple measures of rs-fMRI could significantly enhance the accuracy of other approaches in diagnosing AD. The accuracy obtained by the proposed method was reported for binary classification. More importantly, the classification results of the less commonly reported MCIs vs. MCIc improved significantly. However, this research involved only the AD Neuroimaging Initiative (ADNI) cohort to focus on the diagnosis of AD advancement by integrating sMRI and fMRI. Hence, the study's primary disadvantage is its small sample size. In this case, the dataset we utilized did not fully reflect the whole population. As a result, we cannot guarantee that our findings will be applicable to other populations.

Decoding brain functional connectivity implicated in AD and MCI

Regional Brain Fusion: Graph Convolutional Network for Alzheimer's Disease Prediction and Analysis

Functional Connectivity Network Estimation with an Inter-Similarity Prior for Mild Cognitive Impairment Classification

Predicting MCI to AD Conversation Using Integrated sMRI and rs-fMRI: Machine Learning and Graph Theory Approach

AD Classification Based on Brain Functional Network Using ADNI

Functional Brain Network Measures for Alzheimer's Disease Classification

Resting-state Whole-Brain Functional Connectivity Networks for MCI Classification Using L2-regularized Logistic Regression.

Feature Selection and Combination of Information in the Functional Brain Connectome for Discrimination of Mild Cognitive Impairment and Analyses of Altered Brain Patterns

Sparse Deep Neural Network for Encoding and Decoding the Structural Connectome

Temporal and Spatial Analysis of Alzheimer’s Disease Based on an Improved Convolutional Neural Network and a Resting-State FMRI Brain Functional Network

Functional Brain Network Classification for Alzheimer’s Disease Detection with Deep Features and Extreme Learning Machine

Interpretable Graph Convolutional Network Of Multi-Modality Brain Imaging For Alzheimer’s Disease Diagnosis

Identification of MCI individuals using structural and functional connectivity networks

Extracting Spatial-Temporal Characteristics from Dynamic Connectivity Network with Rs-Fmri Data for AD Classification

Diagnosis of Alzheimer’s Disease with Extreme Learning Machine on Whole-Brain Functional Connectivity

Extracting Sequential Features from Dynamic Connectivity Network with Rs-Fmri Data for AD Classification

Classification of AD, MCI and Controls Using Large-Scale Network Analysis

Intrinsic Functional Component Analysis Via Sparse Representation on Alzheimer's Disease Neuroimaging Initiative Database.

Diagnosis of Early Mild Cognitive Impairment Based on Associated High-Order Functional Connection Network Generated by Multi-Modal MRI

Alzheimer's Disease Diagnosis and Biomarker Analysis Using Resting-State Functional MRI Functional Brain Network With Multi-Measures Features and Hippocampal Subfield and Amygdala Volume of Structural MRI

Classifying Alzheimer's disease with brain imaging and genetic data using a neural network framework